EMA
guidance
· 2022-06-28
Monkeypox: EMA starts review for Imvanex
Summary
EMA initiates a review of Imvanex in relation to Monkeypox to assess available evidence and potential regulatory actions.
Upgrade for the full analysis, importance score, and drug timeline.